Key findings included: 14 percent lower overall risk of developing any substance use disorder 18 percent lower risk of alcohol use disorder (hazard ratio HR 0.82) 14 percent lower risk of cannabis use disorder 20 percent lower risk of cocaine use disorder 20 percent lower risk of nicotine dependence 25 percent lower risk of opioid use disorder These included: 30 percent fewer substance-related emergency department visits 25 percent fewer hospitalizations 40 percent lower overdose risk 50 percent lower risk of drug-related death Possible Mechanism: Effects on Brain Reward Pathways GLP-1 receptor agonists mimic a hormone involved in regulating insulin secretion, appetite, and gastric emptying

Contraindications: Type 1 diabetes Diabetic ketoacidosis Pregnancy and breastfeeding Known hypersensitivity to semaglutide or any excipients Common side effects: Nausea Diarrhea Vomiting Decreased appetite Injection site reactions Serious risks (rare): Pancreatitis Gallstones or inflamed gallbladder Severe allergic reactions Ozempic contains the active ingredient semaglutide (rys) at 1.34 mg/mL concentration
For individuals committed to optimal cellular health, proactive antioxidant support, and comprehensive wellness strategies that address health at fundamental levels, injectable glutathione offers a powerful intervention with well-established biochemical mechanisms and accumulating clinical experience supporting its benefits
Think through the day
To combat the illegal online sale and illegal import of controlled anti-obesity injections, the Department of Health (DH) and Hong Kong Customs carried out a joint enforcement operation yesterday (May 12) in Tin Shui Wai, arresting a 31-year-old woman who was suspected of illegally selling Part 1 poison and an unregistered pharmaceutical product, and importing a pharmaceutical product not under and in accordance with a licence
Over the last few years, the interest in GLP-1 drugs for weight loss has skyrocketed